ArticleScientific reports2025
High intensity interval training and selenium nanoparticles protect hippocampal neurons and enhance cognitive function in diabetic rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Brain-derived neurotrophic factor in diabetes: A promising target for cognitive restoration.iScience · 2026Review
- Sound pressure levels at 40 dB and 50 dB are more suitable for acoustic-cued water maze tests.BMC research notes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive decline is a common complication of diabetes, and is inadequately addressed by current treatments. This study examined the effects of selenium nanoparticles (SeNPs) and high-intensity interval training (HIIT) on cognitive function and neuroprotection in diabetic rats. Male Wistar rats (n = 31) were induced with diabetes and assigned to five groups entered into 8 weeks intervention: control (CO), control which receive placebo (PCO), SeNPs treatment (0.1 mg/kg) (SeNPs), HIIT (HIIT), and combined SeNPs with HIIT (SeNPs + HIIT). Cognitive function was assessed using the Morris water maze test. Hippocampal tissues were analysed for cell viability, gene expression of BDNF, GLUT4, and Irisin receptor, as well as serum protein levels of Irisin and hippocampal BDNF protein level. Results showed that all treatment groups had a significant effect on learning, memory, cell viability, GLUT4, BDNF and irisin (P < 0.03). Serum Irisin was higher in HIIT and SeNPs + HIIT groups (P < 0.0001), also SeNPs and SeNPs + HIIT groups showed increased GLUT4 expression (P < 0.03). SeNPs + HIIT groups had the significant effect on BDNF both gene and protein compared to the all control (CO, PCO) groups (P < 0.01). These findings suggest that combining SeNPs and HIIT may mitigate cognitive decline and promote neuroprotection in diabetes via modulation of Irisin and BDNF pathways and improved glucose metabolism. While synergy is suggested, mechanistic confirmation requires further study. Translational potential exists, but clinical validation is needed due to species differences. Limitations include unmonitored confounders, sample size, and lack of mechanistic validation, highlighting the need for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.